• Product-led growth strategy focused on new products and revenue
• Stronger second half, improved Statutory Revenue and EBITDA
• FY25 pro-forma revenue steady compared to prior year
• Softer FY25 renewals book impacted Statutory Revenue
• Final dividend of 2.00 cents per share, fully franked

Integrated Research (ASX: IRI), a leading global provider of observability for business-critical IT ecosystems, released its results for the financial year ended 30 June 2025. The company experienced stronger second half trading activity compared to the first half. Despite this, a softer FY25 renewals book saw statutory revenue reduce year on year while pro forma revenue, a primary indicator of underlying performance, remained steady year on year. Integrated Research reported EBITDA of $15.9m and NPAT of $13.4m, with operating expenses reduced to $54.9m. The closing cash position was $40.6m, and the company declared a final FY25 dividend of 2.00 cents per share, fully franked. The company's product-led growth strategy announced in August 2024 places product innovation and the commercialisation of new products at the heart of the growth plan. Key highlights include the successful release of High Value Payments (HVP), securing the first new business for Prognosis Elevate, completing development of a beta version of Iris (the company's new AI product), and progressing a new AI-powered stand-alone product offering. While the product-led growth strategy is centered on investing to create innovative new products, it also focuses on revenue performance drivers aligned to achieving sustainable growth, including revenue from new clients, expansion revenue from existing clients, and consumption-based revenue.

The company's product-led growth strategy is designed to position the company for sustainable growth over the medium to long term, though investment in this strategy is expected to reduce profits over the short to medium term. The company holds a blue-chip, global client base, and AI and machine learning are seen as innovation and value accelerators, with the company planning to release its AI product - Iris - in FY26.